Advertisement

Topics

Talecris Biotherapeutics, Inc. and The Alpha-1 Foundation Company Profile

14:22 EDT 26th September 2017 | BioPortfolio


News Articles [1171 Associated News Articles listed on BioPortfolio]

Apic Bio seeded with $1mm

Gene therapy company Apic Bio Inc. spun off from the University of Massachusetts and was seeded with $1mm from the venture philanthropy arm of the Alpha-1 Foundation and private investor Ed Krapels, w...

More Than 600 to Hear Top World Experts on Alpha-1, Genetic Cause of Lung and Liver Disease, at National Conference in Chicago

CHICAGO, June 5, 2017 /PRNewswire/ -- More than 600 people with Alpha-1 Antitrypsin Deficiency – the most common known genetic cause of chronic obstructive pulmonary disease (COPD) – along with th...

X-ray Study Explains How Takinib Inhibits TNF-alpha

Takinib, a selective TAK1 inhibiting drug, has been shown to broaden the therapeutic efficacy of TNF-alpha (Tumor necrosis factor-alpha) inhibition...

Lion Biotechnologies changes name to Iovance Biotherapeutics

Iovance Biotherapeutics, a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, changed its corporate name from Lion Biotechnologies t...

Penn Medicine neurosurgeon named alpha Omega Alpha Fellow in Leadership

(University of Pennsylvania School of Medicine) Timothy H. Lucas, II, MD, PhD, an assistant professor of Neurosurgery and director of the Translational Neuromodulation Lab in the Perelman School of Me...

Alpha Tau Medical Secures Second Funding Round To Treat Solid Tumors With Alpha Radiation

  Life Sciences Jobs   ...

Apic Bio Launches To Advance First-In-Class Gene Therapy For Treatment Of Alpha-1 Antitrypsin Deficiency (Alpha 1)

  Life Sciences Jobs   ...

Pfizer starts work on Missouri biotherapeutics R&D hub

Pfizer is building a $200m (€179m) R&D centre in Chesterfield, Missouri at which it will consolidate biotherapeutics process development operations in the region.

Drugs and Medications [611 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Plasmanate [TALECRIS BIOTHERAPEUTICS, INC.]

Plasma Protein Fraction (Human) 5%, USPPlasmanate®

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

PubMed Articles [719 Associated PubMed Articles listed on BioPortfolio]

Cerebral PET glucose hypometabolism in subjects with mild cognitive impairment and higher EEG high-alpha/low-alpha frequency power ratio.

In Alzheimer's disease (AD) research, both 2-deoxy-2-((18)F)fluoro-D-glucose (FDG) positron emission tomography (PET) and electroencephalography (EEG) are reliable investigational modalities. The aim ...

Prevalence of type I sensitization to alpha-gal in forest service employees and hunters.

The production of IgE molecules specific to the carbohydrate galactose-α-1,3-galactose (alpha-gal) is known to induce delayed anaphylaxis against mammalian meat. Tick bites constitute the primary sen...

DMF as a source of oxygen to access alpha-hydroxy arones via alpha-hydroxylation of arones.

An unprecedented alpha-hydroxylation strategy utilizing DMF as an oxygen source to access alpha-hydroxy arones is described. The results of the control experiments indicated that the "O" of hydroxy gr...

TILT Biotherapeutics.

Alpha-Oxo-Ketenimines from Isocyanides and Alpha-Haloketones: Synthesis and Divergent Reactivity.

The palladium-catalyzed reaction of alpha-haloketones with isocyanides afforded alpha-oxo-ketenimines through beta-hydride elimination of the beta-oxo-imidoyl palladium intermediates. Reaction of thes...

Clinical Trials [1004 Associated Clinical Trials listed on BioPortfolio]

Alpha-1 Foundation Research Registry

The Alpha-1 Foundation Research Registry is a confidential database made up of individuals diagnosed with severe alpha-1 antitrypsin deficiency (Alpha-1) or the carrier state.

Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)

The purpose of this study is to: - evaluate the safety profile of a single intravenous administration of AIGIV (containing either 3.5 mg/kg, 7.0 mg/kg or 14.0 mg/kg anti-PA IgG) a...

Alpha-1 Foundation DNA and Tissue Bank

This is a long-term follow-up banking protocol that collects medical information and tissue (blood, liver and lung) samples for future research; use of data and samples for research purpos...

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

The purpose of the study is to test safety and efficacy of different doses of thymosin alpha 1 (1.6 mg, 3.2 mg, and 6.4 mg) in combination with dacarbazine and with or without Interferon a...

The Safety and Tolerability of Alpha-1 MP In Subjects With Alpha-1-Antitrypsin (AAT) Deficiency

The purpose of this clinical study is to assess the safety and tolerability of Alpha-1 MP in adult Alpha1-antitrypsin deficient patients.

Companies [1481 Associated Companies listed on BioPortfolio]

Talecris Biotherapeutics, Inc. and The Alpha-1 Foundation

Talecris Biotherapeutics Holdings Inc.

Talecris Biotherapeutics (Nasdaq: TLCR) is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders i...

Talecris Biotherapeutics, Inc.

Talecris Biotherapeutics (Nasdaq: TLCR) is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-th...

Talecris Biotherapeutics Holdings Corp.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disor...

Talecris Biotherapeutics

Talecris Biotherapeutics is a new company proud to inherit a legacy of more than 60 years of providing lifesaving and life-enhancing plasma-derived therapeutic proteins. Through the assets of Bayer Bi...

More Information about "Talecris Biotherapeutics, Inc. and The Alpha-1 Foundation" on BioPortfolio

We have published hundreds of Talecris Biotherapeutics, Inc. and The Alpha-1 Foundation news stories on BioPortfolio along with dozens of Talecris Biotherapeutics, Inc. and The Alpha-1 Foundation Clinical Trials and PubMed Articles about Talecris Biotherapeutics, Inc. and The Alpha-1 Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Talecris Biotherapeutics, Inc. and The Alpha-1 Foundation Companies in our database. You can also find out about relevant Talecris Biotherapeutics, Inc. and The Alpha-1 Foundation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record